COLLECTING DUCT CARCINOMA
Clinical trials for COLLECTING DUCT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLLECTING DUCT CARCINOMA trials appear
Sign up with your email to follow new studies for COLLECTING DUCT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail targets rare cancers that have spread
Disease control Recruiting nowThis study is testing a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) in people with rare cancers of the urinary and reproductive systems that have spread to other parts of the body. The goal is to see if this mix can shrink tumors better than any single dr…
Matched conditions: COLLECTING DUCT CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New drug combo targets rare, tough kidney cancers
Disease control Recruiting nowThis study tests a combination of two drugs, pembrolizumab and enfortumab vedotin, for people with rare and aggressive kidney cancers (collecting duct carcinoma and renal medullary carcinoma). About 23 adults with advanced or metastatic disease will receive the treatment for seve…
Matched conditions: COLLECTING DUCT CARCINOMA
Phase: PHASE2 • Sponsor: Giuseppe Procopio • Aim: Disease control
Last updated May 06, 2026 16:03 UTC